UCP Introduces Private, For-Profit Hospitals
EDMONTON, Alberta--(BUSINESS WIRE)--A bill before the Alberta Legislature will, if passed, allow for the operation and funding of hospitals by private, for-profit entities.
Bill 55, The Health Statutes Amendment Act, lets the Health Minister turn hospitals over to private interests, and private operators and charge fees for services.
CUPE Alberta President Raj Uppal joined NDP MLAs and other health care union leaders at the Alberta Legislature to call on the United Conservative Party (UCP) government to scrap the bill.
'Danielle Smith needs to keep her election promise to stay away from private hospitals,' said Uppal. 'Charging fees for health care is mean, and it does nothing to bring down our already high cost of living.'
Uppal said the quality of health care has 'dropped off a cliff' under the UCP's watch, adding that reorganization, scandals like corrupt care, and underfunding 'have added multi levels of chaos' to the system.
'Alberta health care needs stable funding, and quiet, competent management, not American style private hospitals and extra fees.'
clc/cope 491
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
New Research Underscores the Important Role of Value-Based Care (VBC) in Improving Primary Care Access for Traditional Medicare Patients
Study also sheds light on how agilon health's VBC model can enable primary care physicians to provide high-quality care for all seniors, including those with Traditional Medicare WESTERVILLE, Ohio, June 09, 2025--(BUSINESS WIRE)--agilon health (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, today announced new research demonstrating the promising role of value-based care (VBC) in maintaining primary care for senior patients when supported by agilon health, a VBC-enablement company. The study was published in the May 2025 issue of Health Affairs Scholar. "Primary care is foundational for Medicare beneficiaries, especially those with chronic conditions. Despite its importance, many senior patients, particularly ones with Traditional Medicare (TM), have difficulties finding a primary care provider (PCP) and establishing this enormously critical longitudinal relationship," said Karthik Rao, MD, chief medical officer, agilon health. "As PCPs play a key role in providing comprehensive care to patients, we wanted to examine the role of VBC in improving primary care access in this population." Using claims data, researchers compared two groups of PCPs with TM patients in their panels: one group that received support from agilon health to adopt a VBC model and one group that maintained prevailing payment structures, primarily fee-for-service (FFS). Unlike FFS models that reward volume, VBC incentivizes PCPs to spend more time with patients and focus on their quality of care. The following results were observed in the study: After shifting to VBC, PCPs saw eight more new TM patients per year compared to the matched cohort of physicians who did not transition to the full-risk model, representing an approximate 35% relative increase in new TM patient volume, a statistically significant finding (P < 0.001). PCPs shifting to VBC kept their practices open to new TM patients for 0.7 more months per year on average – nearly one full month annually – compared to the other group (P < 0.001), a statistically meaningful increase in availability in the context of shrinking access and PCP workforce shortages nationally. "This study provides timely, independent validation of agilon health's VBC approach, confirming its role in increasing availability of primary care access for Medicare patients, including TM patients who historically face more limited options," added Dr. Rao. "While agilon's model is built around supporting physicians in full-risk arrangements through Medicare Advantage (MA) and ACO REACH contracts, this study shows that our model can have an even greater impact on communities by helping PCPs improve access to care across all of their Medicare patients." Study design Using FFS claims data from 2019 to 2023, researchers compared two groups of PCPs with at least 50 TM patients in their panels: 208 PCPs who received support to adopt a VBC model for TM and MA patients in 2022 ("adopters"), and 3,657 similar PCPs who maintained their existing payment models (FFS) ("nonadopters"). Researchers evaluated changes in two key outcomes between the two groups each year before, during and after VBC adoption. These outcomes included the number of new TM patients seen annually and the number of months each year that physician panels remained open to new TM patients. Researchers used difference-in-differences statistical methods to isolate the effect of joining the VBC model while accounting for other time-based trends. The primary study limitation was the nonexperimental design with a self-selected group of VBC-adopting PCPs. National trends in primary care and the promising role of VBC Access to primary care remains insufficient, despite its critical role in the U.S. healthcare system. Many areas are at risk of becoming "primary care deserts," and even well-resourced health systems have started restricting the acceptance of new patients, regardless of insurance type. Additionally, a national shortage of PCPs is projected to reach 57,000 by 2040. Compounding the issue, Medicare payments have dropped by 29% since 2001 after adjusting for physician practice costs. In response, some PCPs have been limiting new patient intake for TM beneficiaries. VBC models offer a promising path forward, leading to high-quality, cost-effective care. The Center for Medicare & Medicaid Innovation (CMMI) recently announced its goal to increase the share of Medicare beneficiaries in two-sided risk models. Unlike traditional FFS models, full-risk VBC arrangements provide PCPs with fixed payments based on patient demographics and complexity. In exchange, PCPs are held accountable for total medical spending and quality of care. These arrangements incentivize PCPs to proactively manage healthcare needs through efficient team-based approaches. By supporting care delivery transformation, it may also expand PCPs' capacity to serve more patients while maintaining high-quality care. About agilon health agilon health is the trusted partner empowering physicians to transform health care in our communities. Through our partnerships and purpose-built platform, agilon is accelerating at scale how physician groups and health systems transition to a value-based Total Care Model for their senior patients. agilon provides the technology, people, capital, process, and access to a peer network of 2,200+ primary care physicians that allow its physician partners to maintain their independence and focus on the total health of their most vulnerable patients. Together, agilon and its physician partners are creating the healthcare system we need – one built on the value of care, not the volume of fees. The result: healthier communities and empowered doctors. agilon is the trusted partner in 30 diverse communities and is here to help more of our nation's leading physician groups and health systems have a sustained, thriving future. For more information, visit and connect with us on LinkedIn. View source version on Contacts Investor Contacts Evan Smith, CFASVP, Investor Leland Thomasinvestors@ Media Contacts Stephanie LawSenior Director, Marketing & Maureen MerkleCorporate Communicationsmedia@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
Lubrizol Announces an Important Milestone for Its Novel Patented Excipient, Apisolex™ Polymer
CLEVELAND, June 09, 2025--(BUSINESS WIRE)--Lubrizol announces that an Apisolex™ polymer excipient-enabled drug formulation is in Phase 1 clinical trials. Introduced to the market in 2022, Apisolex polymer excipient is a polyamino acid-based polymer that enhances the solubility of BCS Class II and IV active pharmaceutical ingredients (API). Apisolex polymer excipient is manufactured following Good Manufacturing Practices (GMP) guidelines and can be used in dosage forms for various routes of administration, including parenteral. The use of Apisolex polymer excipient has been proven to increase the solubility of certain APIs by as much as 50,000-fold. Apisolex polymer excipient is currently being evaluated in multiple programs across the globe, enabling delivery of hard-to-formulate APIs from various therapeutic classes and by multiple routes. Kevin Song, Senior Director, Global Pharmaceutical and Nutraceutical Business, notes "the progression to clinical trials of a medicinal product formulated with Apisolex polymer excipient demonstrates its ability to provide differentiated solutions to solubility and bioavailability challenges in parenteral formulations." Song adds, "Lubrizol continues to invest in expanding the reach of the Apisolex polymer excipient across global markets and nurturing relationships with drug product manufacturers that are facing insoluble API challenges." About Lubrizol Lubrizol, a Berkshire Hathaway company, is a science-based company whose specialty chemistry delivers sustainable solutions to advance mobility, improve well-being and enhance modern life. Every day, the innovators of Lubrizol strive to create extraordinary value for customers at the intersection of science, market needs and business success, driving discovery and creating breakthrough solutions that enhance life and make the world work better. Founded in 1928, Lubrizol has global reach and local presence, with over 100 manufacturing facilities, sales and technical offices and over 7,000 employees worldwide. For more information, visit View source version on Contacts MEDIA CONTACT Lori Ditty, Global Marketing
Business Wire
an hour ago
- Business Wire
Alliance for Food and Farming: 'Dirty Dozen' List Recommendations Cannot Be Substantiated
WATSONVILLE, Calif.--(BUSINESS WIRE)-- Peer reviewed research published in the Journal of Toxicology found that the recommendation in the 'Dirty Dozen' list to substitute organic forms of produce for conventional does not result in any decrease in risk for consumers because residues on conventionally grown are so low, if present at all. The research also found that the list authors follow no scientifically established methodology in the development of their list. In fact, the 'Dirty Dozen' list authors admit that their list does not assess risk nor do they apply basic tenets of toxicology in the development of their list. From Environmental Working Group's (EWG) previous 'Dirty Dozen' report: 'The Shoppers Guide does not incorporate risk assessment into the calculations. All pesticides are weighted equally, and we do not factor in the levels deemed acceptable by the EPA (Environmental Protection Agency).' Further, the U.S. Department of Agriculture's (USDA) Pesticide Data Program (PDP) consistently finds that over 99% of foods sampled had residue levels well below EPA safety standards with 40% having no detectable residues at all. There is growing concern about the impact of inaccurate safety fears becoming a barrier to increased consumption of produce. One peer reviewed study found that when low income consumers were exposed to 'Dirty Dozen' list messaging, they stated they were less likely to purchase any produce – organic or conventional. In a report released by the Centers for Disease Control (CDC), only one in 10 Americans consume enough fruits and vegetables each day, which is unchanged from previous survey levels announced almost a decade ago. The report states that those living below or close to the poverty level were the least likely to meet produce recommendations. From the CDC: 'Continued efforts to increase fruit and vegetable consumption by improving access and affordability in diverse community and institutional settings will help mitigate health disparities among U.S. residents. Additional policies and programs that will increase access to fruits and vegetables in places where U.S. residents live, learn, work, and play, might increase consumption and improve health.' 'Consumers can and should disregard these types of lists,' says Dr. Sylvia Klinger, DBA, MS, RD, founder of Hispanic and Multicultural Nutrition Communications who serves on the AFF's Management Board. 'Simply follow the advice of dietitians and health experts and choose to eat more fruits and vegetables, which are rich in the vitamins and antioxidants that help our bodies fight and prevent diseases, improve overall health and increase lifespan.' For consumers who are still concerned about residues, the Food and Drug Administration (FDA) states that washing fruits and vegetables under running tap water often removes or eliminates any residues that may be present. (Never use soaps or detergents to wash produce.) Learn more about the safety of all produce at The Alliance for Food and Farming is a non-profit organization formed in 1989 which represents organic and conventional farmers. Alliance contributors are limited to farmers of fruits and vegetables, companies that sell, market or ship fruits and vegetables or organizations that represent produce farmers. Our mission is to deliver credible information about the safety of fruits and vegetables.
